"Neuroprotective Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.
| Descriptor ID |
D018696
|
| MeSH Number(s) |
D27.505.696.706.548 D27.505.954.427.575
|
| Concept/Terms |
Neuroprotective Agents- Neuroprotective Agents
- Agents, Neuroprotective
- Neuroprotectants
- Neuroprotective Drugs
- Drugs, Neuroprotective
Neuroprotective Effect- Neuroprotective Effect
- Effect, Neuroprotective
- Neuroprotective Effects
- Effects, Neuroprotective
|
Below are MeSH descriptors whose meaning is more general than "Neuroprotective Agents".
Below are MeSH descriptors whose meaning is more specific than "Neuroprotective Agents".
This graph shows the total number of publications written about "Neuroprotective Agents" by people in this website by year, and whether "Neuroprotective Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 2 | 5 |
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 4 | 0 | 4 |
| 2003 | 4 | 3 | 7 |
| 2004 | 6 | 0 | 6 |
| 2005 | 4 | 1 | 5 |
| 2006 | 3 | 0 | 3 |
| 2007 | 2 | 0 | 2 |
| 2008 | 4 | 1 | 5 |
| 2009 | 3 | 2 | 5 |
| 2010 | 6 | 3 | 9 |
| 2011 | 4 | 0 | 4 |
| 2012 | 8 | 1 | 9 |
| 2013 | 3 | 2 | 5 |
| 2014 | 5 | 2 | 7 |
| 2015 | 3 | 1 | 4 |
| 2016 | 6 | 4 | 10 |
| 2017 | 3 | 4 | 7 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 2 | 0 | 2 |
| 2021 | 4 | 2 | 6 |
| 2022 | 5 | 0 | 5 |
| 2023 | 2 | 0 | 2 |
| 2024 | 4 | 1 | 5 |
| 2025 | 2 | 2 | 4 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuroprotective Agents" by people in Profiles.
-
Central Administration of Recombinant IGF1 Is Neuroprotective in a Rodent Model of Acute Liver Failure. Int J Mol Sci. 2026 Apr 16; 27(8).
-
How to improve statistical power in a trial with SCA2 patients using natural history data. Trials. 2026 Mar 05; 27(1).
-
Retinal Ischemia: Therapeutic Effects and Mechanisms of Paeoniflorin. Int J Mol Sci. 2025 Nov 11; 26(22).
-
The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique. EBioMedicine. 2025 Aug; 118:105863.
-
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges. Pharmacol Res. 2025 06; 216:107770.
-
Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model. Mol Neurodegener. 2025 Apr 23; 20(1):44.
-
Retinitis Pigmentosa and Therapeutic Candidates. Int Ophthalmol Clin. 2025 01 01; 65(1):17-21.
-
Magnesium sulfate in the management of acute ischemic stroke: A review of the literature and future directions. J Stroke Cerebrovasc Dis. 2025 Feb; 34(2):108188.
-
Pentoxifylline protects memory performance in streptozotocin-induced diabetic rats. Brain Res. 2025 Jan 15; 1847:149319.
-
Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson's disease model. Neurochem Int. 2024 03; 174:105691.